Discontinued — last reported Q1 '20
An increase suggests successful commercialization of intellectual property and strong demand for the company's technology stack, while a decrease may indicate a slowdown in partnership activity or the expiration of licensing contracts.
This metric represents cash inflows or recognized revenue derived from granting third parties the rights to utilize the...
Similar to 'Licensing and Royalty Revenue' or 'Collaboration Revenue' reported by other biotechnology and diagnostic firms, where non-core service revenue is generated through IP monetization.
ntra_segment_licensing_fees_and_prepaid_revenue_proceeds_from_license_agreement